Houston, TX -- (SBWIRE) -- 06/15/2018 -- The global market has been expansively elaborated in a publication added by Research N Reports, titled "Global Cancer/Tumor Profiling Market Research Report 2018." The publication could be a professional guideline for sellers, market investors, to make informed business decisions. The extensive insights offered in the report have been considered to be key for any company looking to cement its position or take an advancement in the market.

Get Sample copy of this report : https://www.researchnreports.com/request_sample.php?id=53969

Applications Covered: Biomarker Discovery, Diagnostics, Personalized Medicine, Prognosis, Research Applications
Technologies Covered: Fluorescence/Chromogenic In Situ Hybridization, Immunohistochemistry, Microarray, Next-Generation Sequencing, Quantitative PCR

Key Players: Agendia Nv, Biotheranostics, Boreal Genomics, Inc., Caris Life Sciences, Genomic Health, Inc., Illumina, Inc., Life Technologies Corporation, Nanostring Technologies, Neogenomics Laboratories, Oncopath Laboratory, Oxford Gene Technology Ltd, Precision Therapeutics, Inc., Proteome Sciences Plc, Rational Therapeutics, and Ribomed Biotechnologies.

According to Stratistics MRC, the Global Cancer/Tumor Profiling market is expected to grow from $23.04 billion in 2015 to reach $78.69 billion by 2022 with a CAGR of 19.2%. Increasing cases of cancer and the need for therapy are the major factors influencing the market growth. Moreover, high investments in R&D, technological developments, and demand for safer medicines are the factors fostering the market growth. However, low awareness among clinicians about options and potential of cancer profiling are the major challenges for this market.

Avail Discount on this report :
https://www.researchnreports.com/ask_for_discount.php?id=53969

By application, personalized medicines segment leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. The growth is attributed by unique characteristics of this segment in examining and prognosis of cancer disease. North America commands the market due to the presence of leading cancer profiling industry leaders. Asia Pacific is expected to witness huge growth due to raising incidence of cancer in this region.

For more information on this report:
https://www.researchnreports.com/enquiry_before_buying.php?id=53969

In this research study, the worldwide market for Cancer/Tumor Profiling has been broadly analyzed on the basis of the type of the product, their application, and the geographical presence of this market. North America, Europe, Southeast Asia, China, Japan, and India have been identified as the main regional markets across the world in this market report.